dostarlimab
gsk
['rectal', 'dostarlimab']
phenomenal 100% complete clinical response rate for 14 consecutive locally advanced #rectalcancer by #dostarlimab presented by published #asco2022 on our way to practice-changing non-operative organ-sparing management in #lynchsyndrome 
MD, PhD, Professor (tenure track), GI surgeon, chief physician at TUNI and TAYS. Johns Hopkins alumni. PI @HelsinkiUniMed Applied Tumor Genomics and HUS